228 related articles for article (PubMed ID: 30119234)
1. Current trends and emerging diagnostic techniques for lung cancer.
Prabhakar B; Shende P; Augustine S
Biomed Pharmacother; 2018 Oct; 106():1586-1599. PubMed ID: 30119234
[TBL] [Abstract][Full Text] [Related]
2. Advanced multimodal diagnostic approaches for detection of lung cancer.
Shende P; Augustine S; Prabhakar B; Gaud RS
Expert Rev Mol Diagn; 2019 May; 19(5):409-417. PubMed ID: 30977684
[TBL] [Abstract][Full Text] [Related]
3. Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Rivera MP; Mehta AC; Wahidi MM
Chest; 2013 May; 143(5 Suppl):e142S-e165S. PubMed ID: 23649436
[TBL] [Abstract][Full Text] [Related]
4. The Role of Artificial Intelligence in Interventional Oncology: A Primer.
Letzen B; Wang CJ; Chapiro J
J Vasc Interv Radiol; 2019 Jan; 30(1):38-41.e1. PubMed ID: 30528289
[No Abstract] [Full Text] [Related]
5. Early detection of lung cancer biomarkers through biosensor technology: A review.
Roointan A; Ahmad Mir T; Ibrahim Wani S; Mati-Ur-Rehman ; Hussain KK; Ahmed B; Abrahim S; Savardashtaki A; Gandomani G; Gandomani M; Chinnappan R; Akhtar MH
J Pharm Biomed Anal; 2019 Feb; 164():93-103. PubMed ID: 30366148
[TBL] [Abstract][Full Text] [Related]
6. Screening and Biosensor-Based Approaches for Lung Cancer Detection.
Wang L
Sensors (Basel); 2017 Oct; 17(10):. PubMed ID: 29065541
[TBL] [Abstract][Full Text] [Related]
7. Will artificial intelligence change the job of the cardiac imaging specialist?
Barone-Rochette G
Arch Cardiovasc Dis; 2020 Jan; 113(1):1-4. PubMed ID: 31899110
[No Abstract] [Full Text] [Related]
8. Fantastic voyage: the future of cancer diagnostics.
Sundaresan TK; Haber DA
Lancet Oncol; 2015 Dec; 16(16):1596-8. PubMed ID: 26678190
[No Abstract] [Full Text] [Related]
9. Electrochemical biosensors for the detection of lung cancer biomarkers: A review.
Khanmohammadi A; Aghaie A; Vahedi E; Qazvini A; Ghanei M; Afkhami A; Hajian A; Bagheri H
Talanta; 2020 Jan; 206():120251. PubMed ID: 31514848
[TBL] [Abstract][Full Text] [Related]
10. Results of diagnostic dilemma between lung cancer and sputum negative pulmonary tuberculosis: a retrospective study.
Dasgupta P; Chakrabarti A; Halder D; Acharyya S; Gangopadhyay S
J Indian Med Assoc; 2012 Dec; 110(12):898-900. PubMed ID: 23936954
[TBL] [Abstract][Full Text] [Related]
11. Early detection of lung cancer by molecular markers in endobronchial epithelial-lining fluid.
Kahn N; Meister M; Eberhardt R; Muley T; Schnabel PA; Bender C; Johannes M; Keitel D; Sültmann H; Herth FJ; Kuner R
J Thorac Oncol; 2012 Jun; 7(6):1001-8. PubMed ID: 22588153
[TBL] [Abstract][Full Text] [Related]
12. Lectin-based biosensors as analytical tools for clinical oncology.
Silva MLS
Cancer Lett; 2018 Nov; 436():63-74. PubMed ID: 30125611
[TBL] [Abstract][Full Text] [Related]
13. Early detection of lung cancers - Comparison of computed tomography, cytology and fuzzy-based tumor markers panels.
Schneider J
Cancer Biomark; 2010; 6(3-4):149-62. PubMed ID: 20660961
[TBL] [Abstract][Full Text] [Related]
14. [The expression of survivin messenger RNA in sputum and cancerous tissue in human lung cancer].
Chen YQ; Li DM; Cai YY; Liu C; Xia XM; Hu JF
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):225-9. PubMed ID: 15854429
[TBL] [Abstract][Full Text] [Related]
15. Acquaintance to Artificial Neural Networks and use of artificial intelligence as a diagnostic tool for tuberculosis: A review.
Dande P; Samant P
Tuberculosis (Edinb); 2018 Jan; 108():1-9. PubMed ID: 29523307
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of 27 patients with lung cancer misdiagnosed as tuberculosis].
Feng TC
Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):458-60. PubMed ID: 2634548
[TBL] [Abstract][Full Text] [Related]
17. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Bharti A; Ma PC; Salgia R
Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
[TBL] [Abstract][Full Text] [Related]
18. [Transbronchial needle aspiration as a diagnostic method in lung cancer and non-malignant mediastinal adenopathy].
Szlubowski A; Kuzdzał J; Soja J; Łaczyńska E; Hauer J; Kopiński P; Tomaszewska R; Zieliński M
Pneumonol Alergol Pol; 2007; 75(1):5-12. PubMed ID: 17541907
[TBL] [Abstract][Full Text] [Related]
19. Tissue hyaluronan expression, as reflected in the sputum of lung cancer patients, is an indicator of malignancy.
Rangel MP; de Sá VK; Martins V; Martins JR; Parra ER; Mendes A; Andrade PC; Reis RM; Longatto-Filho A; Oliveira CZ; Takagaki T; Carraro DM; Nader HB; Capelozzi VL
Braz J Med Biol Res; 2015 Jun; 48(6):557-67. PubMed ID: 25992645
[TBL] [Abstract][Full Text] [Related]
20. Recent developments and advances in secondary prevention of lung cancer.
Rizzo S; Del Grande F; Wannesson L; Froesch P; Giannetto G; Petrella F
Eur J Cancer Prev; 2020 Jul; 29(4):321-328. PubMed ID: 32452945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
